Holmes Biopharma, Inc. (LMB) Earnings
|
Expand Research on LMB
| Next EPS Date | 5/8/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +67.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +12.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/8/24 | Q124 | N/A | $0.42 | N/A | N/A | $132M | = | N/A | N/A | ||
| 3/13/24 | Q423 | $0.44 | $0.40 | +$0.04 | $142.69M | $129.4M | = |  | | Details | |
| 11/8/23 | Q323 | $0.61 | $0.31 | +$0.30 | $127.8M | $126.15M | = | | | Details | |
| 8/9/23 | Q223 | $0.46 | $0.18 | +$0.28 | $124.9M | $119.5M | = | | | Details | |
| 5/17/23 | Q123 | N/A | $0.02 | N/A | N/A | $114.9M | = | N/A | N/A | ||
| 3/8/23 | Q422 | $0.35 | $0.32 | +$0.03 | $143.5M | $154M | = | | | Details | |
| 11/9/22 | Q322 | $0.34 | $0.21 | +$0.13 | $122.36M | $130M | N/A | | | Details | |
| 8/9/22 | Q222 | $0.07 | $0.09 | -$0.02 | $121.02M | $123.18M | N/A | | | Details |
